Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Oncolytics Biotech Inc ONCY


Primary Symbol: T.ONC

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Comment by Quentin30on Feb 05, 2024 12:42pm
425 Views
Post# 35863321

RE:RE:RE:RE:RE:RE:RE:RE:ONCY January 2024 slide deck - over 120 panc pts studied

RE:RE:RE:RE:RE:RE:RE:RE:ONCY January 2024 slide deck - over 120 panc pts studiedare you retarded Noteable..??

I'm just a disgruntled investor who's gotten sick and tired of seeing the the unending just around the corner promises... and the pumper crowd who act as though Matt Coffey walks on water...

I still have money tied up in this piece of doggie sh 1t some call a biotech company... If ONCY does go it alone, then ten years of Matt and his rpedessor Brad on record as stating that they WILL only run a phase III with a partner in place, shows just how pathetic this company has been run, if they are unable to find a willing partner..

This is screaming that something is amiss... how you can continue to pump and then again post about companies in 2024 gettong bought out for 10-15 billion... what drugs are you on?? This company is valued at 3 times it cash on hand...  By Matts own admission, ONCY will need 80 million plus to run the Panc Phase III... 

Unless their data is sufficient to obtain accelerated approval... which means a biomarker that shows statistcially that those patients would benefit from treatment and act as a surrogate for OS... Now WHY is it so hard for Matt to talk about this, when you tout it in every email...

Pumpers like you create false narrative that some would be investors might fall for, and lose money they really didn't need to... shame on you. 
<< Previous
Bullboard Posts
Next >>